IDH1-MUTANT GLIOMA

Clinical trials for IDH1-MUTANT GLIOMA explained in plain language.

Never miss a new study

Get alerted when new IDH1-MUTANT GLIOMA trials appear

Sign up with your email to follow new studies for IDH1-MUTANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for brain tumor patients: drug combo enters trials

Disease control Ongoing

This study tests a new drug, vorasidenib, combined with a standard chemotherapy (temozolomide) in people with a specific type of brain tumor (glioma) that has an IDH1 or IDH2 mutation. The goal is to find the safest dose and see if the combination can help control the tumor. Abou…

Matched conditions: IDH1-MUTANT GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated May 01, 2026 16:00 UTC

IDH1-MUTANT GLIOMA

Get alerted when new IDH1-MUTANT GLIOMA trials appear

New hope for brain tumor patients: drug combo enters trials